HomeNewsTrendsExpert ColumnsCOVID-19 pandemic: India battles to save its newborns in titanic struggle against coronavirus

COVID-19 pandemic: India battles to save its newborns in titanic struggle against coronavirus

Facing the brunt of the coronavirus pandemic are India’s newborn infants, a fact not first acknowledged when the virus broke amidst suggestions that it was only the old and infirm who were in the direct line of fire.

May 19, 2020 / 09:45 IST
Story continues below Advertisement
Migrant workers walk to their villages along the Mumbai Pune highway during 21-day countrywide lockdown in Mumbai, India.
Migrant workers walk to their villages along the Mumbai Pune highway during 21-day countrywide lockdown in Mumbai, India.

On April 19, an 8-day-old baby tested positive for COVID-19 in the Vasai-Virar municipal limits in Maharashtra's Palghar district. The case was registered at the Municipal Corporation’s Juchandra medical facility and despite their best efforts the doctors were unable to save the infant. This made the newborn India’s youngest COVID-19 casualty.

A day earlier, a 45-day-old infant passed away after testing COVID-19 positive at a hospital in New Delhi. Admitted to the Kalawati Saran Children’s Hospital on April 14, one of the biggest in Asia, she had tested positive for the virus on April 16. “Some of the other children admitted in the hospital are too small and on ventilator support. We are making arrangements to place them in safer areas, maybe another hospital with equivalent facilities, to reduce the risk of infection among them," the hospital authorities said in a statement, reflecting the growing panic from virus infection among newborns and infants.

Story continues below Advertisement

A few days ago, a 21-month-old from Kolkata tested positive for COVID-19. A resident of Uttar Panchanna village in south Kolkata, the toddler was immediately shifted to the Belaghata ID and BG Hospital from the Institute of Child Health (ICH) after he tested positive.

Facing the brunt of the coronavirus pandemic are India’s newborn infants, a fact not first acknowledged when the virus broke amidst suggestions that it was only the old and infirm who were in the direct line of fire.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show